Chugai Pharmabody

Global Chugai News Release

Friday, 20 September 2019 6:30 AM

Chugai Obtains Approval for Additional Indication and Formulation for Tecentriq in PD-L1-Positive Triple Negative Breast Cancer

Wednesday, 18 September 2019 7:00 AM

Chugai Selected for the Fifth Time and 2nd Consecutive Year for Dow Jones Sustainability Asia Pacific Index

Friday, 13 September 2019 5:00 AM

Chugai Receives Orphan Drug Designation for Satralizumab in Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder from the Ministry of Health, Labour and Welfare